Loading
NASDAQHealthcareMedical - Diagnostics & Research
Latest quote
$70.91
+$2.70 · +3.96%
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Previous close
$70.91
+$2.70 · +3.96%
After-hours
$70.91
$0.00 · 0.00%
Oct 9, 7:30 PM ET
Regular session · ET · Market data may be delayed.
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Day range
Current $70.91
52-week range
Current $70.91
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
53
Fair Value
Sentiment
56
Mixed
Risk
49
Elevated Risk
Momentum
45
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Day range
Current $70.91
52-week range
Current $70.91
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.04B USD | 1.83B USD | 1.62B USD | 1.43B USD | 1.32B USD |
| Cost of goods sold | 1.95B USD | 1.58B USD | 1.4B USD | 1.26B USD | 1.12B USD |
| Gross profit | 90.8M USD | 249.12M USD | 221.39M USD | 165.72M USD | 191.8M USD |
| Operating expenses | — | 144.49M USD | 122.69M USD | 119.35M USD | 109.25M USD |
| Interest expense | 69.91M USD | 79.85M USD | 64.48M USD | 50.84M USD | 48.83M USD |
| Depreciation and amortization | 152.13M USD | 137.84M USD | 189.49M USD | 184.72M USD | 170.66M USD |
| Operating income | 90.8M USD | 104.62M USD | 98.7M USD | 46.36M USD | 82.55M USD |
| Net income | −18.65M USD | 2.79M USD | 3.04M USD | 10.65M USD | 24.73M USD |
Company facts updated Oct 10, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$65.00
8.33% downside| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Nov 28, 2006 | 1:2 | — | — |
Effective Nov 28, 2006
1:2
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI171.22M0.01%2.3T USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM128.35M0.16%78.27B USD0.19%$278.94+0.49%
Vanguard Morningstar Small-Cap ETFVB123.46M0.07%185.3B USD0.03%$289.48+0.64%
Defiance Quantum ETFQTUM77.3M1.36%5.7B USD0.40%$152.06+0.78%
Vanguard Morningstar Small-Cap Growth ETFVBK70.9M0.16%44.7B USD0.05%$344.74+1.22%
Vanguard Extended Market ETFVXF62.37M0.06%95.4B USD0.05%$235+0.80%
iShares Russell 2000 Growth ETFIWO45.09M0.33%13.97B USD0.24%$356.78+0.94%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM44.43M0.28%15.84B USD0.03%$53.45+0.17%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBDefiance Quantum ETFQTUMVanguard Morningstar Small-Cap Growth ETFVBKVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
